(Q40386878)

20 September 2017

FGFR3 as a therapeutic target of the small molecule inhibitor PKC412 in hematopoietic malignancies (English)

1 reference

20 September 2017

14

Kenneth C Anderson

1 reference

20 September 2017

Jing Chen

1

1 reference

20 September 2017

Benjamin H Lee

2

1 reference

20 September 2017

Ifor R Williams

3

1 reference

20 September 2017

Jeffery L Kutok

4

1 reference

20 September 2017

Constantine S Mitsiades

5

1 reference

20 September 2017

Nicole Duclos

6

1 reference

20 September 2017

Sarah Cohen

7

1 reference

20 September 2017

Jennifer Adelsperger

8

1 reference

20 September 2017

Rachel Okabe

9

1 reference

20 September 2017

Allison Coburn

10

1 reference

20 September 2017

Sandra Moore

11

1 reference

20 September 2017

Brian J P Huntly

12

1 reference

20 September 2017

Doriano Fabbro

13

1 reference

20 September 2017

James D Griffin

15

1 reference

20 September 2017

Dwight Gary Gilliland

16

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 December 2005

1 reference

20 September 2017

1 reference

20 September 2017

24

1 reference

20 September 2017

8259-8267

1 reference

20 September 2017

56

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1208989

20 September 2017

0 references

cites work

Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208989

Incidence and risk factors for thalidomide neuropathy: a prospective study of 135 dermatologic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208989

Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208989

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208989

Phenotypic expression of the fibroblast growth factor receptor 3 (FGFR3) mutation P250R in a large craniosynostosis family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208989

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208989

Preclinical studies of fibroblast growth factor receptor 3 as a therapeutic target in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208989

Molecular remission after allogeneic or autologous transplantation of hematopoietic stem cells for multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208989

PKC412 inhibits the zinc finger 198-fibroblast growth factor receptor 1 fusion tyrosine kinase and is active in treatment of stem cell myeloproliferative disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208989

7 January 2021

Positive and negative regulatory roles of the WW-like domain in TEL-PDGFbetaR transformation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208989

7 January 2021

Constitutively activated FGFR3 mutants signal through PLCgamma-dependent and -independent pathways for hematopoietic transformation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208989

7 January 2021

Activated fibroblast growth factor receptor 3 is an oncogene that contributes to tumor progression in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208989

7 January 2021

PKC412 overcomes resistance to imatinib in a murine model of FIP1L1-PDGFRα-induced myeloproliferative disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208989

7 January 2021

Targeting FGFR3 in multiple myeloma: inhibition of t(4;14)-positive cells by SU5402 and PD173074.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208989

7 January 2021

Breakthroughs in the management of multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208989

7 January 2021

Overexpression of transcripts originating from the MMSET locus characterizes all t(4;14)(p16;q32)-positive multiple myeloma patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208989

7 January 2021

CT53518, a novel selective FLT3 antagonist for the treatment of acute myelogenous leukemia (AML).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208989

7 January 2021

The myeloma-associated oncogene fibroblast growth factor receptor 3 is transforming in hematopoietic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208989

7 January 2021

Thalidomide in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208989

7 January 2021

Deregulated FGFR3 mutants in multiple myeloma cell lines with t(4;14): comparative analysis of Y373C, K650E and the novel G384D mutations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208989

7 January 2021

A subset of multiple myeloma harboring the t(4;14)(p16;q32) translocation lacks FGFR3 expression but maintains an IGH/MMSET fusion transcript

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208989

7 January 2021

The TEL/PDGFbetaR fusion in chronic myelomonocytic leukemia signals through STAT5-dependent and STAT5-independent pathways.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208989

7 January 2021

Inhibition of fibroblast growth factor receptor 3 induces differentiation and apoptosis in t(4;14) myeloma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208989

7 January 2021

Inhibition of mutant FLT3 receptors in leukemia cells by the small molecule tyrosine kinase inhibitor PKC412.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208989

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1208989

1 reference

Dimensions Publication ID

20 September 2017

1024346536

0 references

Fatcat ID

release_kmzuhlq5qnfv5i3jirfcxtstyu

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/kmzuhlq5qnfv5i3jirfcxtstyu

24 November 2022

mapped directly with Wikidata item

1 reference